Online citations, reference lists, and bibliographies.
← Back to Search

Carrier Characteristics Influence The Kinetics Of Passive Drug Loading Into Lipid Nanoemulsions

K. Göke, H. Bunjes
Published 2018 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Graphical abstract Figure. No Caption available. ABSTRACT Passive loading as a novel screening approach is a material‐saving tool for the efficient selection of a suitable colloidal lipid carrier system for poorly water soluble drug candidates. This method comprises incubation of preformed carrier systems with drug powder and subsequent determination of the resulting drug load of the carrier particles after removal of excess drug. For reliable routine use and to obtain meaningful loading results, information on the kinetics of the process is required. Passive loading proceeds via a dissolution‐diffusion‐based mechanism, where drug surface area and drug water solubility are key parameters for fast passive loading. While the influence of the drug characteristics is mostly understood, the influence of the carrier characteristics remains unknown. The aim of this study was to examine how the lipid nanocarriers’ characteristics, i.e. the type of lipid, the lipid content and the particle size, influence the kinetics of passive loading. Fenofibrate was used as model drug and the loading progress was analyzed by UV spectroscopy. The saturation solubility in the nanocarrier particles, i.e. the lipid type, did not influence the passive loading rate constant. Low lipid content in the nanocarrier and a small nanocarrier particle size both increased passive loading speed. Both variations increase the diffusivity of the nanocarrier particles, which is the primary cause for fast loading at these conditions: The quicker the carrier particles diffuse, the higher is the speed of passive loading. The influence of the diffusivity of the lipid nanocarriers and the effect of drug dissolution rate were included in an overall mechanistic model developed for similar processes (A. Balakrishnan, B.D. Rege, G.L. Amidon, J.E. Polli, Surfactant‐mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity, J. Pharm. Sci. 93 (2004) 2064–2075). The resulting mechanistic model gave a good estimate of the speed of passive loading in nanoemulsions. Whilst the drug’s characteristics – apart from drug surface area – are basically fixed, the lipid nanocarriers can be customized to improve passive loading speed, e.g. by using small nanocarrier particles. The knowledge of the loading mechanism now allows the use of passive loading for the straightforward, material‐saving selection of suitable lipid drug nanocarriers.
This paper references
10.1021/MA00111A026
Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions
A. Kabanov (1995)
10.1016/0378-5173(95)04286-5
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
H. Bunjes (1996)
10.1016/S1773-2247(11)50009-7
Drug delivery applications of non-lamellar liquid crystalline phases and nanoparticles
F. Tiberg (2011)
10.1017/S0022112076001663
Brownian diffusion of particles with hydrodynamic interaction
G. Batchelor (1976)
10.1016/j.addr.2012.09.037
Liposomal drug delivery systems: from concept to clinical applications.
T. Allen (2013)
10.1016/0001-8686(94)80041-3
Particle sizing by quasi-elastic light scattering
R. Finsy (1994)
10.1002/JPS.20118
Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.
A. Balakrishnan (2004)
10.1016/j.ejpb.2017.03.010
Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading
K. Rosenblatt (2017)
10.1080/03639040500272108
Dissolution and Solubility Behavior of Fenofibrate in Sodium Lauryl Sulfate Solutions
G. Granero (2005)
10.1002/JPS.2600630403
Mass transport phenomena and models: theoretical concepts.
G. Flynn (1974)
10.1111/j.2042-7158.2010.01024.x
Lipid nanoparticles for the delivery of poorly water‐soluble drugs
H. Bunjes (2010)
10.1208/s12249-010-9526-5
Injectable Lipid Emulsions—Advancements, Opportunities and Challenges
Ketan Hippalgaonkar (2010)
10.1021/la801685v
Impact of oil type on nanoemulsion formation and Ostwald ripening stability.
T. J. Wooster (2008)
10.1016/j.ejpb.2013.02.001
Parenteral formulation of an antileishmanial drug candidate--tackling poor solubility, chemical instability, and polymorphism.
E. Kupetz (2013)
10.1021/acs.molpharmaceut.6b00395
Control over Particle Size Distribution by Autoclaving Poloxamer-Stabilized Trimyristin Nanodispersions.
K. Göke (2016)
10.1016/j.ijpharm.2008.07.002
Theoretical comparison of hydrodynamic diffusion layer models used for dissolution simulation in drug discovery and development.
Kiyohiko Sugano (2008)
10.1023/B:PHAM.0000045237.46019.6e
Supercooled Smectic Nanoparticles: A Potential Novel Carrier System for Poorly Water Soluble Drugs
J. Kuntsche (2004)
Solid lipid nanoparticles production
W. Mehnert (2001)
Abu El Maaty
V. Andermark (2016)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/j.jphotobiol.2009.04.005
Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule?
B. Henry (2009)
10.1016/j.ejpb.2017.05.009
Parameters influencing the course of passive drug loading into lipid nanoemulsions
K. Göke (2018)
10.1016/j.jconrel.2014.06.007
Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
E. Kupetz (2014)
10.1016/J.CEJ.2015.09.022
Instrumented small scale extruder to investigate the influence of process parameters during premix membrane emulsification
S. Gehrmann (2016)
10.1021/JS930336P
Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine.
J. Crison (1996)
10.1016/j.jinorgbio.2015.12.020
Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.
Vincent Andermark (2016)
Injectable lipid emulsions – advancements
K. Hippalgaonkar (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar